23.11.2020 CompuGroup Medical SE & Co. KGaA  DE000A288904

DGAP-Adhoc: CompuGroup Medical SE & Co. KGaA acquires eMDs


 

DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Mergers & Acquisitions
CompuGroup Medical SE & Co. KGaA acquires eMDs

23-Nov-2020 / 08:08 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Today, CompuGroup Holding USA, Inc., a 100 % subsidiary of CompuGroup Medical SE & Co. KGaA ("Company"), and MDeverywhere Midco, Inc., USA, the sole indirect shareholder of eMDs, Inc., USA (jointly "eMDs"), have entered into an agreement regarding acquisition of 100 % issued and outstanding capital stock of eMDs. The competent corporate bodies of the Company have already approved the transaction.

eMDs' key products are Ambulatory Information Systems and outsourcing services for the accounting of medical services. CGM is thus strengthening its position in the USA significantly and, after the acquisition, will be the top 4 in the market for Ambulatory Information Systems in the USA based on the number of independent doctors' practices which are not part of a hospital.

The transaction is structured as a reverse triangular merger under U.S. law. The consideration to be paid to the current shareholders of eMDs is based on an enterprise value of approx. USD 240 million (approx. EUR 203 million), which will be adjusted inter alia for amounts of cash, financial debt and net working capital (compared to a reference amount) as of the closing date. In the fiscal year 2019/2020 (ended 2020/03/31), eMDs generated revenues of approx. EUR 81 million and an EBITDA of approx. EUR 12 million with more than 60.000 healthcare providers.

Closing of the transaction is expected by the end of 2020 and is in particular subject to approvals by the U.S. merger control and investment control authorities.


23-Nov-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1149807

 
End of Announcement DGAP News Service

1149807  23-Nov-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1149807&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 543,07 560,20 582,38 717,02 745,81 837,26 1.030,00
EBITDA1,2 112,32 125,67 128,44 187,84 178,13 197,48 221,00
EBITDA-Marge3 20,68 22,43 22,05 26,20 23,88 23,59 21,46
EBIT1,4 67,77 81,84 90,07 143,23 115,27 121,77 139,00
EBIT-Marge5 12,48 14,61 15,47 19,98 15,46 14,54 13,50
Jahresüberschuss1 38,62 44,47 31,74 96,34 66,15 73,42 83,00
Netto-Marge6 7,11 7,94 5,45 13,44 8,87 8,77 8,06
Cashflow1,7 73,25 67,61 85,82 136,35 110,50 149,93 0,00
Ergebnis je Aktie8 0,77 0,90 0,63 1,92 1,33 1,40 1,55
Dividende8 0,35 0,35 0,35 0,50 0,50 0,50 0,55
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
CompuGroup Medical
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A28890 68,150 Halten 3.662,01
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
36,84 37,48 0,95 70,19
KBV KCV KUV EV/EBITDA
5,99 24,42 4,37 20,98
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,50 0,55 0,81 19.05.2022
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
05.05.2022 04.08.2022 04.11.2021 24.03.2022
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-5,61% -4,54% -13,30% -8,22%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu CompuGroup Medical SE & Co. KGaA  ISIN: DE000A288904 können Sie bei DGAP abrufen

Software , A28890 , COP , XETR:COP